Wagner, M. (2018) “COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA”, Journal of Population Therapeutics and Clinical Pharmacology, 16(2). Available at: https://mail.jptcp.com/index.php/jptcp/article/view/549 (Accessed: 19 November 2024).